Opendoor Technologies Inc. (OPEN): Nasdaq/NYSE listing notice — Opendoor receives Nasdaq deficiency notice for bid price below $1.00

Opendoor Technologies Inc.

Closing bid price of OPEN common stock below $1.00 for 30 consecutive business days.
Given 180 calendar days, until November 24, 2025, to regain compliance.
To cure, stock must close at $1.00+ for 10 consecutive business days.
If not cured, may seek transfer to Nasdaq Capital Market for additional 180-day period.
Company considering options including a reverse stock split; no assurance of compliance.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 1.0

Opendoor Technologies Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1), 5810(c)(3)(A)

Exact text from the filing

May 28, 2025, Opendoor Technologies Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the closing bid price for the Company’s common stock, par value $0.0001 per share (the “Common Stock”), has fallen below $1.00 per share for 30 consecutive business days, the Company no longer meets the minimum bid price requirement for continued listing on the Nasdaq Global Select Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”). The N

View on SEC.gov

3 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Opendoor Technologies Inc. filing history →

Source: SEC EDGAR

accession 0001801169-25-000042

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.